Corrigendum: Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece

Front Med (Lausanne). 2018 Jan 24:4:257. doi: 10.3389/fmed.2017.00257. eCollection 2017.

¹ First Academic Department of Pneumonology, Hospital for Diseases of the Chest "Sotiria", Medical School, National and Kapodistrian University of Athens, Athens, Greece.
² Division of Immunology, Biomedical Sciences Research Center "Alexander Fleming", Athens, Greece.
³ 5th Respiratory Department, Hospital for Diseases of the Chest "Sotiria", Athens, Greece.
⁴ Department of Pneumonology, University Hospital of Alexandroupolis, Democritus University of Thrace, Komotini, Greece.

Abstract

[This corrects the article on p. 213 in vol. 4, PMID: 29238708.].

Keywords: efficacy; idiopathic pulmonary fibrosis; pirfenidone; safety; treatment.